NCT02592460

Brief Summary

Animal studies have shown that the level of pain sensitivity is highly dependent on the amount of polyamines in food. This fundamental observation of a nutritional approach to pain led the authors to develop diets completely depleted in polyamines whose anti-nociceptive properties have been confirmed in animals. Postoperative pain after foot surgery are currently fairly well controlled but at the cost of a high consumption of grade II analgesics which is associated with a high rate of side effects (nausea, vomiting ...). The investigators' hypothesis is that a diet low in polyamines may have an additive effect on pain control and reduce the consumption of level 2 analgesics. The objective of this study is to show the efficacy of a polyamines-poor diet on postoperative pain in ambulatory surgery of the foot.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
542

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Dec 2014

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 30, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

February 15, 2019

Status Verified

October 1, 2017

Enrollment Period

2.6 years

First QC Date

October 29, 2015

Last Update Submit

February 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients whose worst pain, as measured on an visual analogic scale ranging from 0 mm to 100 mm, was at least once rated as 30 mm or more.

    The worst pain will be assessed retrospectively the eighth day after surgery

    Eight days after surgery

Secondary Outcomes (3)

  • Percentage of patients with a need for grade II analgesics

    Eighth day after surgery

  • Overall tramadol consumption , expressed in mg.

    Eight days after surgery

  • Worst pain, expressed in mm, measured on an visual analogic scale ranging from 0 mm to 100 mm

    Eight days after surgery

Study Arms (2)

poor-polyamines diet

EXPERIMENTAL
Other: poor-polyamines diet

high-polyamines diet

ACTIVE COMPARATOR
Other: high polyamines diet

Interventions

Patients in this will receive a poor-polyamines diet during a week before and a week after foot surgery

poor-polyamines diet

Patients in this will receive a high-polyamines diet during a week before and a week after foot surgery

high-polyamines diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • foot ambulatory orthopedic surgery

You may not qualify if:

  • other diet susceptible to interfere with the poor or high-polyamines diets (e.g. diabetic patients)
  • contraindication to tramadol or to NSAIDs
  • pregnant or breastfeeding woman
  • patient under legal protection
  • patient's opposition to participate in the study
  • poor understanding of French
  • absence of affiliation to social security
  • participation to another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe hospitalier Diaconesses Croix Saint Simon

Paris, Île-de-France Region, 75020, France

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2015

First Posted

October 30, 2015

Study Start

December 1, 2014

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

February 15, 2019

Record last verified: 2017-10

Locations